Braxia Scientific (XCNQ:BRAX) LT-Debt-to-Total-Asset : 0.21 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Braxia Scientific's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.21.

Braxia Scientific's long-term debt to total assets ratio increased from Dec. 2022 (0.01) to Dec. 2023 (0.21). It may suggest that Braxia Scientific is progressively becoming more dependent on debt to grow their business.

Braxia Scientific LT-Debt-to-Total-Asset Historical Data

The historical data trend for Braxia Scientific's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific LT-Debt-to-Total-Asset Chart

Braxia Scientific Annual Data

Trend

Mar21

Mar22

Mar23

LT-Debt-to-Total-Asset

0.01

0.03

Braxia Scientific Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial												0.01	0.03	0.05	0.18	0.21

Braxia Scientific LT-Debt-to-Total-Asset Calculation

Braxia Scientific's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (A: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2023 )	/	Total Assets (A: Mar. 2023 )
	=	0.131	/	3.884
	=	0.03

Braxia Scientific's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0.501	/	2.338
	=	0.21

Braxia Scientific (XCNQ:BRAX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Braxia Scientific LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Braxia Scientific (XCNQ:BRAX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

BRAXF:USA 4960:Germany

Address

700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6

Website

https://www.braxiascientific.com

Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines